u/marisol_moreau

New plan year, entirely new criteria, and the denial that had been immovable in the autumn simply did not apply in January.

Correcting myself upthread: the deadline was 3 days, not the figure I gave.

keep every date, every reference number, every name of a department

deadlines run from the letter date, not from when you opened it

an online consultation that asks you nothing is not a consultation

discharge at goal back to the GP is where a lot of people fall over

Not convinced by the comparison. Different services, different gradients, and you are treating one as ground truth.

This. Hypoglycaemia risk in this class is driven mostly by the other agents in the regimen.

Right, and keeping every date and reference number turns a frustrating process into an auditable one.

Same. My ICB threshold was different from the neighbouring one and nobody could tell me why.

What has been documented as tried, and for how long?

Discharge from a specialist service at goal is a normal end point of that pathway. Whether prescribing continues in primary care afterwards is a local decision and is worth asking about at the start rather than at the end.

Two years and four months on a tier 3 list.

This is why national advice does not work here. It is commissioned locally and it varies.

net peptide content if the report gives it, and say which you are quoting

GP said no in the spring, specialist said yes eighteen months later.

Disagreeing with this line: that is the arrangement in one nation and the question is about another.

Same view. The second-level appeal is where mine turned, after a first-level denial that looked final.

This. Hypoglycaemia risk in this class is driven mostly by the other agents in the regimen.

results without method are gossip with decimals

That advice is jurisdiction-specific and this board spans several. Say where you are.

Four observations is not a distribution. The lane tables here only became predictive once individual routes had a dozen or more reports behind them.

Small fix — shipped from the regional warehouse, not from origin, which is why the number looks unusual.

I would not skip the peer-to-peer. It is often the fastest route and it costs a phone call.

Correction: that was clearance time, not carrier time. The lane table separates them for exactly this reason.

declared value and description are the shipper’s decision, ask what they use

nothing here replaces the person managing your diabetes

Same. ERP quoted 14 days on my lane and it landed at 8, which is exactly what you want from a quote.

net peptide content if the report gives it, and say which you are quoting

Certain conditions affect A1c independently of glycaemia. If a result looks inconsistent with the sensor data, that is a question for whoever manages your care rather than for this board.

Assumed the weight endpoints from the obesity trials applied to my situation. They are different programmes.

Correction: that was clearance time, not carrier time. The lane table separates them for exactly this reason.

Ordered from the warehouse in Ireland instead of origin and the whole customs question disappeared. 12 days, door to door.

dose for glycaemic control is not the same conversation as dose for weight

A1c, CGM, or fingersticks — which are we discussing?

Why this board reports by lane and not by supplier.

Agreed — and the decomposition matters. Most people are blaming the international leg for a last-mile problem.

Push back: comparing a July transit with a February one on the same lane is not a comparison.

Small fix — shipped from the regional warehouse, not from origin, which is why the number looks unusual.

Packaging is assessable on arrival with no equipment: rigid outer, no movement inside, the cold element sized to the transit rather than to the box.

Appeal deadlines run from the date on the determination letter. They are strict, they are short, and a missed deadline usually forfeits that level entirely.

The template is vendor, compound, batch, service, claim, result, and who paid.

This is why the template has a batch field. Without it the result is about a vial nobody can identify.

Date of analysis anchors the result to a manufacturing period. A two-year-old result is evidence about two years ago and should be read that way.